Protalix BioTherapeutics (PLX) Receivables - Net (2010 - 2026)
Protalix BioTherapeutics (PLX) recorded Receivables - Net of $16.5 million in Q2 2026, up 74.8% from $9.44 million a year earlier and up 461.5% from the prior quarter.
Powered by 
Analysis
Protalix BioTherapeutics (PLX) Receivables - Net (2010 - 2026) Analysis & Trends
At the end of FY2025, Protalix BioTherapeutics reported Receivables - Net of $8.84 million, up 203.9% from FY2024.
- Annual Receivables - Net has a five-year compound annual growth rate of 34.6% (FY2020 to FY2025).
- Across earlier years, Receivables - Net came in at $2.91 million in FY2024 (-44.8%), $5.27 million in FY2023 (+15.0%), $4.59 million in FY2022 (+33.2%) and $3.44 million in FY2021 (+72.1%).
- The Q2 2026 figure is the highest quarterly Receivables - Net in data going back to Q4 2010.
- On a year-over-year basis, Receivables - Net rose in four of the last eight quarters, with growth averaging 87.0%.
- Peak year-over-year performance for Receivables - Net in the last five years was growth of 557.2% in Q3 2025, against a decline of 77.9% in Q1 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $2.94 million (Q1 2026), $8.84 million (Q4 2025) and $14.43 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Protalix BioTherapeutics | 207.16 Mn | 55.78 Mn | 12.13 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.50 Mn |
| Mar 31, 2026 | 2.94 Mn |
| Dec 31, 2025 | 8.84 Mn |
| Sep 30, 2025 | 14.43 Mn |
| Jun 30, 2025 | 9.44 Mn |
| Mar 31, 2025 | 4.68 Mn |
| Dec 31, 2024 | 2.91 Mn |
| Sep 30, 2024 | 2.20 Mn |
| Jun 30, 2024 | 10.13 Mn |
| Mar 31, 2024 | 3.76 Mn |
| Dec 31, 2023 | 5.27 Mn |
| Sep 30, 2023 | 8.94 Mn |
| Jun 30, 2023 | 4.05 Mn |
| Mar 31, 2023 | 1.30 Mn |
| Dec 31, 2022 | 4.59 Mn |
| Sep 30, 2022 | 8.65 Mn |
| Jun 30, 2022 | 2.02 Mn |
| Mar 31, 2022 | 5.91 Mn |
| Dec 31, 2021 | 3.44 Mn |
| Sep 30, 2021 | 5.56 Mn |
API Access
Protalix BioTherapeutics Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=PLX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "PLX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=PLX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();